Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
123.50    -0.50 (-0.40%)
Bid:
122.00
Ask:
125.00
Spread: 3.00 (2.459%)
Market Cap: £41.18m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Publication of a Prospectus

13 Apr 2026 12:19

RNS Number : 2295A
Onward Opportunities Limited
13 April 2026
 

This announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares of Onward Opportunities Limited in any jurisdiction, including in or into or from the United States of America, Australia, Canada, Japan, the Republic of South Africa or in any other jurisdiction.

 

13 April 2026

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

Publication of Prospectus

 

Onward Opportunities Limited (TIDM: ONWD), the investment company targeting opportunities in UK smaller companies, is pleased to announce the publication of a prospectus (the "Prospectus") in relation to the proposed admission of its ordinary shares (the "Ordinary Shares") to listing on the closed-ended investment funds segment of the Official List of the Financial Conduct Authority (the "FCA") and to trading on the Main Market for listed securities of the London Stock Exchange (together, "Admission").

 

It is expected that: (i) Admission will take place at 8.00 a.m. on 16 April 2026; and (ii) the Ordinary Shares will be cancelled from trading on AIM at 8.00 a.m. on 16 April 2026. The last day of trading of the Ordinary Shares on AIM is therefore expected to be 15 April 2026.

 

Onward Opportunities is not offering any new Ordinary Shares nor any other securities in connection with the proposed Admission. Following Admission, the Ordinary Shares will continue to be registered with their existing ISIN of GG00BMZR1514 and the TIDM will remain ONWD.

 

The Company's shareholders should consult their own professional advisers regarding the consequences of Admission for them.

 

The Prospectus has been approved by the FCA and will shortly be available to view on the Onward Opportunities website, www.onwardopportunities.co.uk. A copy of the Prospectus will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

For further information, please contact:

 

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Lead Fund Manager

 

 

Via Houston

 

 

Cavendish Capital Markets Limited

Ben Jeynes / Seamus Fricker

Chris West / Matt Lewis - Sales and ECM

 

Tel: +44 (0)20 7220 0500

Houston (PR advisers)

Charlie Barker / Nick Jackman 

 

Tel: +44 (0)77 3303 2695

Onward@houston.co.uk

 

 

 

For more information please visit: www.onwardopportunities.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIMZGMDMFKGVZM
12
Date   Source Headline
4th Jun 202611:57 amRNSNet Asset Value(s)
2nd Jun 202612:26 pmRNSPublication of May 2026 Factsheet
1st Jun 202612:03 pmRNSNet Asset Value(s)
28th May 202612:12 pmRNSNet Asset Value(s)
21st May 202611:34 amRNSNet Asset Value(s)
14th May 202612:17 pmRNSNet Asset Value(s)
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20264:39 pmRNSPurchase of Shares by the Portfolio Manager
7th May 20263:51 pmRNSPublication of April 2026 Factsheet - Replacement
7th May 202612:44 pmRNSPublication of April 2026 Factsheet
7th May 202611:50 amRNSNet Asset Value(s)
1st May 202611:31 amRNSNet Asset Value(s)
1st May 20267:01 amRNSTotal Voting Rights
1st May 20267:00 amRNSIssue of Equity
30th Apr 202611:54 amRNSNet Asset Value(s)
24th Apr 20267:00 amRNSIssue of Equity
23rd Apr 202611:54 amRNSNet Asset Value(s)
21st Apr 20262:12 pmRNSHolding(s) in Company
21st Apr 202610:24 amRNSPublication of Q1 2026 Factsheet
20th Apr 20269:05 amRNSBlock Admission Application
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20261:10 pmRNSNet Asset Value(s)
16th Apr 20268:00 amRNSReadmission - Onward Opportunities Limited
16th Apr 20267:00 amRNSAdmission to Main Market and AIM Cancellation
15th Apr 20269:29 amRNSResult of AGM
14th Apr 20262:46 pmRNSPurchase of Shares by Portfolio Manager
13th Apr 202612:19 pmRNSPublication of a Prospectus
9th Apr 20265:30 pmRNSOnward Opportunities
1st Apr 20264:13 pmRNSNet Asset Value(s)
26th Mar 202611:25 amRNSUpdate re Main Market Listing and Notice of AGM
2nd Mar 20264:56 pmRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSIntended Main Market Listing
2nd Mar 20267:00 amRNSAnnual Results
5th Feb 20268:39 amRNSChange of Adviser
2nd Feb 20264:45 pmRNSNet Asset Value(s)
21st Jan 20264:04 pmRNSHolding(s) in Company - Replacement
21st Jan 20269:52 amRNSHolding(s) in Company
20th Jan 202610:34 amRNSHolding(s) in Company
19th Jan 20267:00 amRNSAdditional Subscription and Total Voting Rights
12th Jan 20267:00 amRNSIssue of Equity
12th Jan 20267:00 amRNSFull-Year Update
6th Jan 202612:00 pmRNSPublication of Q4 2025 Factsheet
2nd Jan 20264:05 pmRNSNet Asset Value(s)
31st Dec 202512:14 pmRNSHolding(s) in Company
31st Dec 202512:14 pmRNSHolding(s) in Company
4th Dec 20251:21 pmRNSDirector/PDMR Shareholding
1st Dec 20254:04 pmRNSNet Asset Value(s)
25th Nov 202511:34 amRNSHolding(s) in Company
19th Nov 20257:00 amRNSAdditional Subscription and Total Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.